Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: June 2008
-
By Kevin E. Noonan — American opinion has finally turned in support of the idea that global warming, and ecological concerns in general, are relevant and important to themselves and their children (despite years of opposition, both formal and informal, from the current Administration and its fellow-travelers from energy corporations and the right…
-
By Donald Zuhn — Yesterday, Gilead Sciences, Inc. announced that the U.S. Patent and Trademark Office had issued a Notice of Intent to Issue an Ex Parte Reexamination Certificate for U.S. Patent No. 5,922,695. The ‘695 patent became the second of Gilead’s four Viread® (tenofovir disoproxil fumarate) patents to survive reexamination. Last month,…
-
By Donald Zuhn — The U.S. Patent and Trademark Office published a notice in the Federal Register today proposing adjustments to certain patent fees for fiscal year 2009. The adjustments are intended to reflect fluctuations in the Consumer Price Index (CPI). Written comments regarding the proposed adjustments can be submitted at the Federal…
-
By Donald Zuhn — Last month, Larkspur, California-based biotech Jivan Biologics, Inc. announced that the U.S. Patent and Trademark Office had granted its request for an ex parte reexamination of U.S. Patent No. 6,881,571, which is owned by ExonHit Therapeutics S.A. The ‘571 patent is directed to devices for identifying differentially spliced gene…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Wyeth v. Sandoz Inc.1:08-cv-00317; filed May 28, 2008 in the District Court of Delaware Infringement of U.S. Patent No. 6,500,814 ("Hormonal Contraceptive,"…
-
June 4, 2008 – Biotechnology/Chemical/Pharmaceutical Customer Partnership Meeting (U.S. Patent and Trademark Office) June 11, 2008 – Advanced Patent Licensing 2008: What You Need to Know Before Licensing Your Patent (Practising Law Institute) – San Francisco, CA June 16, 2008 – Prior Art & Obviousness 2008: The PTO and CAFC Perspective on Patent Law Sections…
Patent Docs 